Gastrin-releasing peptide and other autocrine growth factors in lung cancer: pathogenetic and treatment implications
- PMID: 3042610
Gastrin-releasing peptide and other autocrine growth factors in lung cancer: pathogenetic and treatment implications
Similar articles
-
Growth factors and lung cancer.Cancer Treat Res. 1995;72:111-30. doi: 10.1007/978-1-4615-2630-8_5. Cancer Treat Res. 1995. PMID: 7702983 Review. No abstract available.
-
Peptide hormones and lung cancer.Panminerva Med. 2006 Mar;48(1):19-26. Panminerva Med. 2006. PMID: 16633328 Review.
-
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.J Clin Invest. 1996 Feb 1;97(3):806-13. doi: 10.1172/JCI118480. J Clin Invest. 1996. PMID: 8609238 Free PMC article.
-
Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.Cell Growth Differ. 1996 May;7(5):563-72. Cell Growth Differ. 1996. PMID: 8732666
-
Gastrin-releasing peptide-related peptides in a human malignant lung carcinoid tumor.Cancer Res. 1983 Nov;43(11):5411-5. Cancer Res. 1983. PMID: 6616473
Cited by
-
Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers.J Clin Invest. 1989 Oct;84(4):1105-13. doi: 10.1172/JCI114273. J Clin Invest. 1989. PMID: 2794048 Free PMC article.
-
Immunomodulatory functions of the diffuse neuroendocrine system: implications for bronchopulmonary dysplasia.Endocr Pathol. 2004 Summer;15(2):91-106. doi: 10.1385/ep:15:2:091. Endocr Pathol. 2004. PMID: 15299196 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical